COMPANY INFO
Flora is a private company founded in 2022 and headquartered in Chicago, IL. It has 9 employees and operates in the electronic equipment and instruments industry. Flora manufactures electronic sensors designed to offset carbon in the atmosphere by saving plants. Their sensors use artificial intelligence to provide real-time insights and custom alerts for plant care, helping plant owners maintain plant health remotely. The company raised $300K in funding and aims to remove guesswork from plant care with its technology. (PitchBook, CB Insights)
Flora (Flora Brands) is an innovative private company specializing in electronic sensors that leverage AI to support plant health and offset atmospheric carbon. Founded in 2018 and headquartered in Amsterdam, Flora operates globally with a mission to revolutionize plant care and sustainability through technology.
The Flora leadership team is composed of experienced executives and entrepreneurs with deep backgrounds in technology, finance, manufacturing, and consumer goods. The Flora management team is recognized for driving growth across international markets, championing strategic acquisitions, and advancing R&D by integrating expertise from sectors such as electronic manufacturing, retail, finance, and human resources. The company’s founders and key leaders work collaboratively to ensure Flora’s continued innovation and market expansion.
Clifford Starke serves as Chairman and CEO of Flora Growth Corp., overseeing all aspects of the company’s mission to become a leading small-cap international cannabis company on NASDAQ. Under his leadership, Flora has pursued global expansion strategies, successfully advocating for industry regulations, and growing a worldwide team of more than 100 professionals.
With an entrepreneurial career spanning over a decade, Clifford Starke has specialized in cannabis and finance, arranging more than a billion dollars in funding and investing in multiple billion-dollar companies. He previously helmed Hampstead Private Capital Ltd. and Franchise Global Health, and he holds a Bachelor’s degree in History from Queen’s University.
Dany Vaiman, CPA, CA, CPA (Illinois) is the Chief Financial Officer for Flora Growth and leads all financial operations, including IPO execution, M&A, reporting, and systems design. Dany played a pivotal role in Flora’s landmark acquisition of Franchise Global Health, enhancing the company's financial structure and international reach.
Dany brings more than 15 years of public company finance experience, previously holding CFO and Corporate Controller roles at Franchise Global Health and Torex Gold Resources, respectively. He is a Chartered Accountant and holds a BBA in Accounting from York University’s Schulich School of Business.
Daniela Rondon Rendon leads Flora International LLC and is responsible for high-impact growth strategies, client loyalty, and technology-driven initiatives. Her experience spans budget management, HR, and leadership of cross-functional teams within Flora’s technology division.
Daniela offers over nine years of expertise in both the service and tangible product sectors and was previously commercial manager at Adecco. She holds degrees in Business Administration and Marketing from Escuela Colombiana de Mercadeo, underscoring her proficiency in commercial development.
Zina Ghabra Katabi plays a leading governance role as a board member and Head of the HR Committee at Flora, driving human resources strategy and organizational development.
Zina holds a Bachelor’s in Business Administration with a major in HR Management from DeVry University and has contributed to Flora’s talent and HR policies for over six years.
Sonja Frick was instrumental as Project Director at Flora Growth, spearheading the expansion of Flora’s CPG brand portfolio into new markets. She is highly skilled in product strategy, market entry, and leading distributed teams for Flora’s growth initiatives.
With vast experience in the retail and CPG space, including senior roles at Macy’s, Sonja holds a BA from Boston College and has also studied at the University of Edinburgh.
Josh Fields leads Flora Skin Therapy LLC, focusing on growth and manufacturing advancements in the skincare sector for Flora.
Josh brings over 14 years of entrepreneurial expertise as CEO of Flora Skin Therapy and is based in Cedar Rapids, Iowa.
Irene Flora serves as Vice President at Flora Fine Foods, utilizing her longstanding consulting experience to guide strategy and leadership within the company’s skincare and food division.
With more than 48 years at Flora Fine Foods, Irene holds an Associate of Arts degree from Broward Community College.
Flora T oversees team management and policy development at Harry Winston, with a focus on recruitment, training, and corporate compliance.
She has held the Director role at Harry Winston for over five years and is based in the United States.
Bob Flora manages flora gardening, directing operations, business development, and customer engagement in the sector.
Bob holds an MBA from the University of Southern California and works out of Saratoga, California.
The Flora leadership team is structured for global impact, leveraging extensive expertise across technology, finance, manufacturing, and consumer products. With collaborative management and a presence in multiple countries, the Flora executives guide the company’s key initiatives, corporate governance, and market innovation. The company’s founders and executive leadership team are dedicated to Flora’s mission of sustainable growth and technological disruption in plant care.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Flora (Flora Brands) leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.